“…In the present study, when the bismuth shielding tablets were tested for protecting the front of the body and the front and sides of the body, the dose measured at the two ovaries did not differ considerably, because the dose was mainly incident from the direction of the main X-rays; hence, shielding the front of the body blocks most of the dose, and the scattered dose produced on both sides of the body is relatively small. In pelvic radiology, positioning of the automatic exposure-control (AEC) chambers, pelvic orientation, and gonadal shielding can potentially optimize the radiation dose and the image quality [ 5 , 18 ]. However, those authors concluded that using gonadal shielding can increase the dose area product, leading to repeated radiography exams, especially in female examinations, which raises the question of the actual utility of gonadal shielding in female pelvic radiography.…”